Table 5.

1, 3, 5‐year survival

	1 year (%)	3 years (%)	5 years (%)	P value
Overall
Male	39	23	16	0.026
Female	48	29	21
Surveillance group
Male	53	30	22	0.836
Female	57	34	20
Symptomatic group
Male	21	9	5	0.056
Female	27	14	10